JP3491027B2 - Oral composition - Google Patents
Oral compositionInfo
- Publication number
- JP3491027B2 JP3491027B2 JP07511996A JP7511996A JP3491027B2 JP 3491027 B2 JP3491027 B2 JP 3491027B2 JP 07511996 A JP07511996 A JP 07511996A JP 7511996 A JP7511996 A JP 7511996A JP 3491027 B2 JP3491027 B2 JP 3491027B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- oral composition
- bitterness
- sodium chloride
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 239000011780 sodium chloride Substances 0.000 claims description 12
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical group NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 8
- 229960000401 tranexamic acid Drugs 0.000 claims description 8
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 claims description 7
- 239000001738 pogostemon cablin oil Substances 0.000 claims description 7
- 239000001735 hyssopus officinalis l. herb oil Substances 0.000 claims description 6
- 239000010670 sage oil Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000010676 star anise oil Substances 0.000 claims description 6
- 210000000214 mouth Anatomy 0.000 claims 1
- 235000019658 bitter taste Nutrition 0.000 description 16
- 235000002639 sodium chloride Nutrition 0.000 description 16
- -1 isomentone Chemical compound 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 6
- 235000019480 chamomile oil Nutrition 0.000 description 6
- 239000010628 chamomile oil Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 239000002324 mouth wash Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 4
- 229940051866 mouthwash Drugs 0.000 description 4
- 235000019477 peppermint oil Nutrition 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- 239000005973 Carvone Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 208000028169 periodontal disease Diseases 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 2
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 2
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000003997 cyclic ketones Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000001683 mentha spicata herb oil Substances 0.000 description 2
- 229930007503 menthone Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019721 spearmint oil Nutrition 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【発明の属する技術分野】この発明は、抗プラスミン剤
を含有する口腔組成物に関し、更に詳細には、優れた使
用感を有し、歯周疾患の予防に効果的な口腔用組成物に
関する。TECHNICAL FIELD The present invention relates to an oral composition containing an antiplasmin agent, and more particularly to an oral composition having an excellent feeling of use and effective in preventing periodontal disease.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】従来よ
り、抗プラスミン剤が炎症や止血に優れた効果を持って
おり、歯周病の予防に対し有効であることが知られてお
り、口腔用組成物への配合が検討、提案されている。2. Description of the Related Art Conventionally, antiplasmin agents have been known to have excellent effects on inflammation and hemostasis, and are known to be effective in preventing periodontal disease. The composition of the composition has been studied and proposed.
【0003】しかし、トラネキサム酸及び/又はその塩
に代表される抗プラスミン剤を配合した口腔用組成物
は、特有の苦味や辛味を持つために、実際に使用するた
めには、それを改善する必要がある。さらに、トラネキ
サム酸及び/又はその塩に代表される抗プラスミン剤を
配合した口腔用組成物は、長期保存した場合に、香味立
ちが劣化するなど、香料の安定性が悪く、これに対する
改善も必要である。However, an oral composition containing an antiplasmin agent typified by tranexamic acid and / or a salt thereof has a peculiar bitterness and pungency, and therefore it is necessary to improve it for practical use. There is a need. Furthermore, an oral composition containing an antiplasmin agent typified by tranexamic acid and / or a salt thereof has poor stability of a fragrance such as deterioration of flavor and the like when stored for a long period of time, and it is necessary to improve it. Is.
【0004】従来、抗プラスミン剤を配合した口腔用組
成物の使用感改善方法として、カルボン及びl−メント
ールを併用して配合すること(特公昭61−29323
号)、アルデヒド香料等とメントン、イソメントン、プ
レゴンから選ばれる環状ケトンの1種又は2種以上を配
合すること(特公平7−74139号)が検討されてい
るが、カルボンは、スペアミント油の、l−メントール
はペパーミント油の主要成分であり、どちらも口腔用組
成物(の香料)の汎用素材として一般的に使用されてい
るものであり、また、アルデヒド香料等とメントン、イ
ソメントン、プレゴンから選ばれる環状ケトンの1種又
は2種以上を配合することというのも、これらもペパー
ミント油の構成成分であるため、ペパーミント油を当該
口腔用組成物に配合すれば、実施できてしまうはずであ
り、口腔組成物を作成するにあたっての一般的な手段と
いえ、抗プラスミン剤を配合した口腔用組成物に限って
の使用感、経時安定性の改善方法とは判断できず、ま
た、長期保存による香味立ちの劣化の抑制効果としては
十分でなく、より使用感、経時安定性の良い当成分配合
の口腔用組成物の開発が望まれていた。Conventionally, as a method for improving the feeling of use of an oral composition containing an antiplasmin agent, carvone and 1-menthol are used in combination (Japanese Patent Publication No. 61-92323).
No.), an aldehyde perfume and the like and one or more cyclic ketones selected from menthone, isomentone and pulegone (Japanese Patent Publication No. 7-74139) are being considered, but carvone is a spearmint oil. 1-Menthol is a main component of peppermint oil, both of which are commonly used as a general-purpose material for (or fragrances) of oral compositions, and also selected from aldehyde fragrances and the like, menthone, isomentone, and pulegone. The compounding of one or more cyclic ketones is also because these are also constituent components of peppermint oil, so if peppermint oil is compounded in the oral composition, it should be possible to implement it. It can be said that it is a general method for preparing an oral composition, but it has a feeling of use and is stable over time only for an oral composition containing an antiplasmin agent. It is not possible to judge that it is a method of improving the property, and it is not sufficient as an effect of suppressing deterioration of flavoring due to long-term storage, and it is desired to develop an oral composition containing this component having a better feeling in use and stability over time. Was there.
【0005】[0005]
【課題を解決するための手段及び作用】本発明者らは、
上記事情に鑑み鋭意検討を重ねた結果、抗プラスミン剤
を含有する口腔組成物に、塩化ナトリウムとスターアニ
ス油、セージ油、ナツメグ油、パチュリ油、カモミール
油、ヒソップ油からなる群より選ばれた少なくとも1種
又は2種以上を併用して配合した場合、意外にも抗プラ
スミン剤の苦味が顕著にマスキングされ、使用感が向上
し、長期保存による香味立ちの劣化を抑制するという新
たな知見を発見し、本発明をなすにいたった。以下、本
発明につき詳しく説明する。Means and Actions for Solving the Problems The present inventors have
As a result of repeated intensive studies in view of the above circumstances, an oral composition containing an antiplasmin agent was selected from the group consisting of sodium chloride and star anise oil, sage oil, nutmeg oil, patchouli oil, chamomile oil, and hyssop oil. Surprisingly, when at least one type or two or more types are used in combination, surprisingly, the bitterness of the antiplasmin agent is remarkably masked, the feeling of use is improved, and the deterioration of flavor standing due to long-term storage is suppressed. Discovered and made the present invention. Hereinafter, the present invention will be described in detail.
【0006】[0006]
【発明の実施の形態】本発明に用いられる抗プラスミン
剤としては、イプシロンアミノカプロン酸、トラネキサ
ム酸及び/又はその塩が挙げられるが、トラネキサム酸
及び/又はその塩において,もっとも顕著な改善効果が
認められる。その配合量は、特に制限はないが、組成物
全体の0.01〜5重量%、特に0.03〜3重量%と
することがより好ましい。BEST MODE FOR CARRYING OUT THE INVENTION Examples of the antiplasmin agent used in the present invention include epsilon aminocaproic acid, tranexamic acid and / or its salt. Tranexamic acid and / or its salt show the most remarkable improving effect. To be The blending amount is not particularly limited, but is preferably 0.01 to 5% by weight, and more preferably 0.03 to 3% by weight based on the entire composition.
【0007】本発明に用いられる塩化ナトリウムとして
は、通常の試薬のほか、食用塩、岩塩、海水の濃厚溶液
等が使用できる。その配合量は、組成物全体の0.5〜
30重量%、特に1〜15重量%とすることが好まし
い。配合量が30%より多いと、 塩化ナトリウムの
塩辛みが出てしまい、0.5%より少ないと十分な効果
が発揮されない 。As the sodium chloride used in the present invention, in addition to ordinary reagents, edible salt, rock salt, concentrated solution of seawater, etc. can be used. The compounding amount is 0.5 to 0.5 of the whole composition.
It is preferably 30% by weight, particularly preferably 1 to 15% by weight. If the blending amount is more than 30%, saltiness of sodium chloride will occur, and if it is less than 0.5%, a sufficient effect will not be exhibited.
【0008】本発明でも用いられる精油は、スターアニ
ス油、セージ油、ナツメグ油、パチュリ油、カモミール
油、ヒソップ油からなる群より選ばれた少なくとも1種
又は2種以上であり、中でもナツメグ油、パチュリ油、
カモミール油、ヒソップ油が好ましい。またその配合量
は、組成物全体の1重量%を越えて配合すると苦味や、
べたつき感が出現する場合があり、使用感を損ねるた
め、また、0.001重量%以下では苦味低減効果が発
揮されないため、0.001〜1重量%、特に0.00
1〜0.5重量%とすることが好ましい。更に、塩化ナ
トリウムとスターアニス油、セージ油、ナツメグ油、パ
チュリ油、カモミール油、ヒソップ油からなる群より選
ばれた少なくとも1種又は2種以上の配合比は、1:
2 〜 1: 600であるのが好ましい。The essential oil used in the present invention is at least one kind or two kinds or more selected from the group consisting of star anise oil, sage oil, nutmeg oil, patchouli oil, chamomile oil, and hyssop oil . Among them, nutmeg oil, Patchouli oil,
Chamomile oil and hyssop oil are preferred. In addition, the blending amount of the composition is more than 1% by weight, bitterness and
In some cases, a sticky feeling may appear, which impairs the feeling of use, and when 0.001% by weight or less, the bitterness-reducing effect is not exhibited, so 0.001 to 1% by weight, particularly 0.001% by weight.
It is preferably 1 to 0.5% by weight. Furthermore, the compounding ratio of at least one or two or more selected from the group consisting of sodium chloride and star anise oil, sage oil, nutmeg oil, patchouli oil, chamomile oil, and hyssop oil is 1:
It is preferably from 2 to 1: 600.
【0010】本発明の口腔用組成物は、練歯磨、潤製歯
磨、液状歯磨等の歯磨類、マウスウオッシュ、トロー
チ、チューインガム、口腔用パスタ、歯肉マッサージク
リーム、液状口中清涼剤、固形状口中清涼剤として調整
することができ、上記に加えてそれぞれの種類に応じた
種々の公知成分を本発明の効果が損なわれない範囲で配
合することができる。例えば、ラウリル硫酸ナトリウ
ム、ラウロイルサルコシンナトリウム、ラウリン酸ジエ
タノールアマイド、ショ糖脂肪酸エステル、ポリオキシ
エチレンソルビタン脂肪酸エステル、ポリオキシエチレ
ン硬化ヒマシ油、ポリオキシエチレンとポリオキシプロ
ピレンのブロックコポリマーなどの界面活性剤(配合量
0〜5%)グリセリン、ソルビット、ポリエチレングリ
コール、プロピレングリコール、ヘキシレングリコール
などの湿潤剤(配合量1〜40%)、ヒドロキシエチル
セルロース、カルボキシメチルセルロース、メチルセル
ロース、カルボキシプロピルセルロース、プロピルセル
ロース、カラギーナン、アルギン酸ナトリウム、キサン
タンガム、ポリビニルアルコール、ポリビニルピロリド
ンのような粘結剤(配合量0.1〜5.0%)、場合に
よっては、第2リン酸カルシウム、炭酸カルシウム、水
酸化アルミニウム、沈降性シリカ等のシリカ系研磨剤、
さらに、サッカリンナトリウム、ステビオサイド、キシ
リトールなどの甘味剤、メント−ル、カルボン、アネト
ール、オイゲノール、サリチル酸メチル、ペパーミント
油、スペアミント油、冬緑油、丁子油、ユーカリ油、レ
モン油、オレンジ油などの香料、色素、防腐剤、pH調
整剤を配合することができる。また、有効成分として、
デキストラナーゼ、ムタナーゼ、リゾチーム等の酵素、
モノフルオロリン酸ナトリウムやフッ化ナトリウムなど
のフッ素化合物、トリクロサン、クロルヘキシジン類、
塩化セチルピリジニウムなどの第4級アンモニウム、ヒ
ノキチオール、銅クロロフィリンナトリウム、トラネキ
サム酸、グリチルレチン酸、グリチルリチン酸塩、アズ
レン、ポリリン酸塩の1種又は2種以上を配合すること
ができる。The oral composition of the present invention is a toothpaste such as toothpaste, moisturized toothpaste, liquid toothpaste, mouthwash, troche, chewing gum, oral pasta, gingival massage cream, liquid mouth freshener, solid mouth freshener. It can be adjusted as an agent, and in addition to the above, various known ingredients corresponding to the respective types can be added within a range in which the effects of the present invention are not impaired. For example, surfactants such as sodium lauryl sulfate, sodium lauroyl sarcosine, diethanolamide laurate, sucrose fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, block copolymer of polyoxyethylene and polyoxypropylene ( Blending amount 0-5%) Wetting agents such as glycerin, sorbit, polyethylene glycol, propylene glycol, hexylene glycol (blending amount 1-40%), hydroxyethyl cellulose, carboxymethyl cellulose, methyl cellulose, carboxypropyl cellulose, propyl cellulose, carrageenan, Caking agents such as sodium alginate, xanthan gum, polyvinyl alcohol, polyvinylpyrrolidone (compounding amount 0.1-5.0 ), In some cases, dicalcium phosphate, calcium carbonate, silica abrasives such as aluminum hydroxide, precipitated silica,
In addition, sweeteners such as sodium saccharin, stevioside, xylitol, menthol, carvone, anethole, eugenol, methyl salicylate, peppermint oil, spearmint oil, wintergreen oil, clove oil, eucalyptus oil, lemon oil, orange oil and other flavors, Dyes, preservatives and pH adjusters can be added. Also, as an active ingredient,
Enzymes such as dextranase, mutanase, lysozyme,
Fluorine compounds such as sodium monofluorophosphate and sodium fluoride, triclosan, chlorhexidines,
One or more of quaternary ammonium such as cetylpyridinium chloride, hinokitiol, sodium copper chlorophyllin, tranexamic acid, glycyrrhetinic acid, glycyrrhizinate, azulene and polyphosphate can be blended.
【0011】[0011]
【実施例】つぎに、実施例を挙げて本発明をさらに詳細
に説明するが、本発明はこれらに制限されるものではな
い。
実施例および比較例
処方例1、2に示す洗口剤を常法に従ってを調製し、下
記方法で苦味ならびに香味の経時安定性を評価した。結
果を表1に示す。評価結果は10名のパネラーの平均点
を四捨五入した値で表した。EXAMPLES Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these. Examples and Comparative Examples The mouthwashes shown in Formulation Examples 1 and 2 were prepared according to a conventional method, and the bitterness and the flavor were evaluated for stability over time. The results are shown in Table 1. The evaluation results are shown by rounding off the average score of 10 panelists.
【0012】 処方1(塩化ナトリウム配合処方) 成分 配合量(重量%) トラネキサム酸 0.05 塩化ナトリウム 1.5 表1に示す精油 0.05 グリセリン 13.00 エタノール 7.00 サッカリンナトリウム 0.005 ポリオキシエチレン硬化ヒマシ油(60) 0.35 香料 0.20 水 残部 計 100.0[0012] Prescription 1 (prescription with sodium chloride) Ingredient amount (% by weight) Tranexamic acid 0.05 Sodium chloride 1.5 Essential oil shown in Table 1 0.05 Glycerin 13.00 Ethanol 7.00 Saccharin sodium 0.005 Polyoxyethylene hydrogenated castor oil (60) 0.35 Perfume 0.20 Remaining water 100.0 in total
【0013】 処方2(塩化ナトリウム無配合処方) 成分 配合量(重量%) トラネキサム酸 0.05 表1に示す精油 0.05 グリセリン 13.00 エタノール 7.00 サッカリンナトリウム 0.005 ポリオキシエチレン硬化ヒマシ油 (60) 0.35 香料 0.20 水 残部 計 100.0[0013] Prescription 2 (prescription without sodium chloride) Ingredient amount (% by weight) Tranexamic acid 0.05 Essential oil shown in Table 1 0.05 Glycerin 13.00 Ethanol 7.00 Saccharin sodium 0.005 Polyoxyethylene hydrogenated castor oil (60) 0.35 Perfume 0.20 Remaining water 100.0 in total
【0014】苦味評価方法
調製した洗口液約20mlで30秒間洗口し、口に含ん
でから吐出後口中に残る苦味の程度を4段階で下記評価
基準により官能評価した。
(評価基準)
苦味なし 4
ほとんど苦味なし 3
やや劣る 3
やや苦味あり 2
苦味あり 1Bitterness Evaluation Method About 20 ml of the prepared mouthwash was rinsed for 30 seconds, and the degree of bitterness remaining in the mouth after being contained in the mouth was sensory-evaluated according to the following evaluation criteria in four stages. (Evaluation criteria) No bitterness 4 Almost no bitterness 3 Somewhat inferior 3 Somewhat bitterness 2 Some bitterness 1
【0015】香味の安定性評価
調製直後の洗口液ならびに40℃で1ヶ月間放置した洗
口液を用い、約20mlで30秒間洗口し、4段階で下
記評価基準により官能評価した。
(評価基準)
1ケ月放置後の香味立ちが放置前のものとほぼ同等 4
1ケ月放置後の香味立ちが放置前よりやや劣る 3
1ケ月放置後の香味立ちが放置前より劣る 2
1ケ月放置後の香味立ちが放置前よりかなり劣る 1Evaluation of Stability of Flavor Using the mouthwash immediately after preparation and the mouthwash left at 40 ° C. for 1 month, the mouth was rinsed with about 20 ml for 30 seconds, and sensory evaluation was performed in four stages according to the following evaluation criteria. (Evaluation Criteria) The flavoring after one month left is almost the same as that before leaving. 4 The flavoring after one month left is slightly inferior to that before leaving. 3 The flavor standing after one month is inferior to before leaving for two months. The flavor afterward is considerably inferior to that before leaving 1
【0016】(総合評価) 苦味、経時安定性の評価が いずれもが3以上でいずれかが4 ◎ いずれもが3 ○ いずれかが2 △ いずれかが1 ×(Comprehensive evaluation) Evaluation of bitterness and stability over time All are 3 or more and either is 4 ◎ All are 3 ○ Either is 2 △ Either 1x
【0017】[0017]
【表1】 [Table 1]
【0018】表1の結果から明らかなごとく、抗プラス
ミン剤を含有した口腔用組成物では、特有の苦味を有す
るが、塩化ナトリウムとスターアニス油、セージ油、ナ
ツメグ油、パチュリ油、カモミール油、ヒソップ油から
なる群より選ばれた少なくとも1種又は2種以上を併用
して配合すると、苦味が抑制され、しかも、長期保存に
よる香味立ちの劣化が効果的に抑制され、非常に経時安
定性、使用感の高いものとなる。また、実施例と比較例
を比較しても、塩化ナトリウムを配合しただけでは、苦
味、経時安定性の改善とはならず、スターアニス油、セ
ージ油、ナツメグ油、パチュリ油、カモミール油、ヒソ
ップ油からなる群より選ばれた少なくとも1種又は2種
以上と塩化ナトリウムを併用して配合してはじめて苦
味、経時安定性の改善が効率よくおこなわれることが確
認された。As is clear from the results of Table 1, the oral composition containing the antiplasmin agent has a peculiar bitterness, but sodium chloride and star anise oil, sage oil, nutmeg oil, patchouli oil, chamomile oil, When used in combination with at least one or two or more selected from the group consisting of hyssop oil, bitterness is suppressed, and further deterioration of flavoring due to long-term storage is effectively suppressed, and stability over time, It has a high usability. In addition, even if the examples and the comparative examples are compared, the addition of sodium chloride does not improve the bitterness and stability over time, and star anise oil, sage oil, nutmeg oil, patchouli oil, chamomile oil, and hyssop It has been confirmed that the bitterness and the temporal stability are efficiently improved only when sodium chloride is used in combination with at least one or two or more selected from the group consisting of oils.
【0019】[0019]
【発明の効果】本発明の口腔用組成物は、従来から問題
とされている抗プラスミン剤特有の苦味、辛味がほとん
どなく、優れた使用感を有し、かつ香味の経時安定性に
すぐれ、歯周疾患の予防改善に好適である。EFFECTS OF THE INVENTION The oral composition of the present invention has little bitterness and pungency peculiar to the conventional anti-plasmin agents, has an excellent feeling in use, and is excellent in flavor stability over time. It is suitable for preventing and improving periodontal diseases.
Claims (2)
ターアニス油、セージ油、ナツメグ油、パチュリ油、ヒ
ソップ油からなる群よりえらばれた少なくとも1種又は
2種以上を併用してなることを特徴とした口腔用組成
物。1. An antiplasmin agent and sodium chloride and at least one kind selected from the group consisting of star anise oil, sage oil, nutmeg oil, patchouli oil , and hyssop oil, in combination, Composition for oral cavity.
はその塩である請求項1記載の口腔用組成物。2. The oral composition according to claim 1, wherein the antiplasmin agent is tranexamic acid and / or a salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP07511996A JP3491027B2 (en) | 1996-03-04 | 1996-03-04 | Oral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP07511996A JP3491027B2 (en) | 1996-03-04 | 1996-03-04 | Oral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH09241140A JPH09241140A (en) | 1997-09-16 |
| JP3491027B2 true JP3491027B2 (en) | 2004-01-26 |
Family
ID=13567000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP07511996A Expired - Fee Related JP3491027B2 (en) | 1996-03-04 | 1996-03-04 | Oral composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3491027B2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0303675D0 (en) * | 2003-02-18 | 2003-03-19 | Quest Int | Improvements in or relating to flavour compositions |
| JP5634844B2 (en) * | 2010-12-10 | 2014-12-03 | 花王株式会社 | Bitter taste inhibitor |
| JP5874383B2 (en) * | 2011-12-21 | 2016-03-02 | ライオン株式会社 | Oral composition |
| JP6281926B1 (en) * | 2017-05-18 | 2018-02-21 | 長岡香料株式会社 | Taste improver for high-intensity sweeteners |
| JP6296473B1 (en) * | 2017-05-18 | 2018-03-20 | 長岡香料株式会社 | Bitter taste inhibitor |
-
1996
- 1996-03-04 JP JP07511996A patent/JP3491027B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09241140A (en) | 1997-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4574081A (en) | Antiplaque dentifrice having improved flavor | |
| EA001791B1 (en) | Dentrifice composition | |
| JP4261744B2 (en) | Oral composition | |
| KR0169139B1 (en) | Mild oral hygiene compositions that preserve taste | |
| JP2002029950A (en) | Oral composition containing zinc compound | |
| JPH10501265A (en) | Mouth rinse composition | |
| JP3491027B2 (en) | Oral composition | |
| FR2471780A1 (en) | TOOTHPASTE COMPOSITION | |
| US20040258631A1 (en) | Oral care compositions exhibiting antiplaque and breath freshening properties | |
| JP3987593B2 (en) | Oral composition containing sodium chloride and magnesium chloride | |
| JP2627709B2 (en) | Oral composition | |
| JP4044748B2 (en) | Oral liquid composition | |
| JP4632553B2 (en) | Oral composition | |
| JPH11322554A (en) | Composition for oral cavity | |
| JP3582571B2 (en) | Oral liquid preparation | |
| JP3189549B2 (en) | Oral composition | |
| JP4158036B2 (en) | Dentifrice composition and method for producing the same | |
| JP3511727B2 (en) | Oral composition | |
| JPH07258050A (en) | Oral composition | |
| JP3814142B2 (en) | Oral composition | |
| JP2001322921A (en) | Liquid oral composition | |
| JP2002020254A (en) | Dentifrice composition | |
| JP7635508B2 (en) | Oral Composition | |
| JPH0995429A (en) | Composition containing sodium chloride and used for oral cavity | |
| JP3412872B2 (en) | Oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20030924 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081114 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081114 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091114 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101114 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111114 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121114 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121114 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131114 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |